Duvelisib

Status:
Do Not Prescribe (DNP)
Decision Date:
None
 

Comments

DNP:

  • NICE TA717for treating relapsed follicular lymphoma after 2 or more systemic therapies. (Terminated appraisal) (Decision date - August 2021)
  • NICE TA811 - for treating relapsed or refractory chronic lymphocytic leukaemia after 2 or more treatments (terminated appraisal) (Decision date - August 2022)

Do Not Prescribe (DNP) Drug Classifications

  • 6: Have NICE guidance that recommends they should not be used

search again

Derby and Derbyshire ICB

Derby and Derbyshire ICB

Please click the button to navigate to our app

Redirect to app